Table 2. Angiographic and procedural characteristics in matched groups.

Matched	IERRA-75 N = 686	Control N = 686	P	95% CI
Data are presented as mean ± SD or n (%).
Radial access	598 (87.1%)	609 (88.7%)	0.36	−1.86% to 5.07%
Complex PCI	389 (56.7%)	408 (59.5%)	0.25	−2.42% to 7.99%
Number of diseased vessels	1.76 ± 0.8	1.72 ± 0.8	0.35	−0.12% to 0.045%
1 vessels	324 (47.2%)	343 (50%)	0.29	−2.48% to 8.06%
2 vessels	206 (30%)	200 (29.1%)	0.70	−3.92% to 5.72%
3 vessels	156 (22.7%)	143 (20.8%)	0.40	−2.47% to 6.26%
Number of lesions treated	1.43 ± 0.7	1.42 ± 0.72	0.79	−0.085% to 0,065%
Intravascular imaging	49 (7.1%)	45 (6.5%)	0.65	−2.1% to 3.3%
Clopidogrel	522 (76%)	497 (72.5%)	0.34	−1.13% to 8.11%
Ticagrelor	164 (24%)	189 (27.5%)	0.14	−1.13% to 8.11%
Oral anticoagulants	120 (17.5%)	113 (16.4%)	0.58	−2.88% to 5.08%
Lesions treated	N = 982	N = 974	P	95% CI
Minimum lumen diameter,	0.91 ± 0.8	0.93 ± 0.8	0.50	−0.051% to 0.091%
Reference vessel diameter,	3 ± 0.55	3.01 ± 0.52	0.70	−0.037% to 0.057%
Angiographic stenosis, %	87.6 ± 11	88 ± 11	0.49	−0.58% to 1.38%
B2/C lesion type	412 (60%)	434 (63.2%)	0.22	−1.11% to 7.49%
Calcium (moderate/severe)	212 (30.9%)	225 (32.8%)	0.40	−2.23% to 6.02%
Bifurcation	119 (17.3%)	125 (18.2%)	0.66	−2.49% to 4.29%
Chronic total occlusion	65 (9.5%)	80 (11.6%)	0.20	−0.63% to 4.84%
Stent length, mm	21.5 ± 8	22 ± 8	0.24	−0.21% to 1.21%
Stent diameter, mm	2.96 ± 0.54	2.97 ± 0.55	0.73	−0.038% to 0.058%
Angiographic success	677 (98.7%)	671 (97.8%)	0.28	−0.29% to 2.15%